AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURE VENTURES PLC

Pre-Annual General Meeting Information May 30, 2023

4993_rns_2023-05-30_fe7ce919-98bc-46dc-9eb4-bf6cac02dc87.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9902A

MaxRets Ventures PLC

30 May 2023

30 May 2023

MaxRets Ventures plc

("MaxRets Ventures" or the "Company")

Notice of AGM

MaxRets Ventures, (AQUIS:MAX), an investing company focussing on early-stage or undervalued later stage businesses with strong upside potential, announces that the Company's Annual General Meeting ("AGM") will be held at 3:00 p.m. on Thursday, 22 June 2023 at 50, Sloane Avenue, London, SW3 3DD.

The Notice of AGM (the "Notice") and Form of Proxy are today being sent to shareholders and will shortly be available on the Company's website, www.maxrets.com.

Shareholders are encouraged to complete, sign and return the Form of Proxy accompanying the Notice to the Company's Registrar, Share Registrars Limited, as soon as possible but in any event so as to be received not later than 3.00 p.m. on 20 June 2023. The return of a Form of Proxy will not preclude a shareholder from attending and voting at the Annual General Meeting in person, should they subsequently decide to do so.

For further information please contact:

Enquiries:

MaxRets Ventures plc

Dominic White, Non-Executive Chairman
c/o Walbrook PR Ltd
Cairn Financial Advisers LLP

AQSE Corporate Adviser

Jo Turner/Emily Staples
+44 20 7213 0880
Walbrook PR Limited

Paul Vann/Nick Rome
+44 20 7933 8780

+44 7768 807631

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFIFEEELIIVIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.